We are pleased to announce that Buffalo Business First has named Pine Pharmaceuticals a 2023 Manufacturer Award winner. This award recognizes Pine as one of the top family-run businesses in the manufacturing industry and honors owners Al Sr. and Alfonse J. Muto for...
Staying current
and connected
See what we are doing, where we are going, and how we are shaping our industry every day.
Pine Pharmaceuticals assumes Athenex’s 503B business, preserving over 50 jobs, expanding its product offerings, and serving hospitals and health systems nationwide
Tonawanda, NY, May 3, 2023 /PRNewswire/– Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, today announced the successful integration of Athenex's 503B business, including the transfer of people, processes,...
2023 Conferences and Trade Shows
March 17 - 19, 2023 Dallas, TXMay 17 - 20, 2023 Louisville, KY Learn moreMay 22 - 24, 2023 Indianapolis, IN Learn moreJuly 28 - August 1, 2023 Seattle, WA Learn moreAugust 15 - 16, 2023 Las Vegas, NV Learn moreJune 10 - 12, 2022 Orlando, FL Learn moreNovember 3 - 6,...
Pine owners recognized as one of the top Family Businesses of 2022
Buffalo Business First has named Pine Pharmaceuticals a 2022 Family Business Award winner. This recognition will honor owners Al Sr. and Alfonse J. Muto as one of the top multi-generational, family-owned businesses in Western New York. In early 1985, Al Sr. founded...
Here’s how to master your bevacizumab inventory
Always having drug products readily available at your practice can be a challenge. But fear not: Pine is here to help. We have compiled our top three tips for mastering inventory management so you can always keep repackaged bevacizumab on hand; ready to administer....
Introducing: TPC+K and TPC+T Combination Drops
Now joining our family of top-selling combination drops, Pine Pharmaceuticals is excited to announce our latest product innovations in ophthalmology: TPC+K and TPC+T. Working diligently to keep our promise, we listened to your feedback and carefully...
Pine announces expansion completion, tripling facility size and doubling workforce
After the announcement of our expansion in December 2021, Pine Pharmaceuticals is pleased to share the completion of our 50,000-square-foot state-of-the-art facility. Designed to comply with the US Food and Drug Administration's Current Good Manufacturing Practice...
Owners Al Sr. and Alfonse J. Muto recognized for second consecutive year as Fast 46 finalists
After being recognized in 2021, we are excited to share that Pine Pharmaceuticals' owners Al Sr. and Alfonse J. Muto will be honored at The University at Buffalo's 2022 "Fast 46" ceremony for a second consecutive year! Named in honor of UB's founding in 1846, Fast 46...
Three easy ways Pine can help support your practice in the new year
Are you looking to improve your practice in 2022? Pine is here to support you! Below are our top three strategies to improve your practice in the New Year. Best of all, when you partner with Pine, achieving your goals is easier than ever! Goal #1: Be More...
University at Buffalo recognizes owners Al Sr. and Alfonse J. Muto
The University at Buffalo recently recognized Pine Pharmaceuticals owners Al Sr. and Alfonse J. Muto during their inaugural "Fast 46" program. Named in honor of UB's founding in 1846, Fast 46 recognizes and celebrates the success of 46 of the fastest-growing...